Home/ Stocks/ VIVS

VivoSim Labs, Inc. Common Stock

VIVS XNAS

$0.29 -0.01 (-2.05%) ▼ 15-min delayed

Open

$0.29

High

$0.30

Low

$0.28

Volume

237.7K

Market Cap

$3.82M

About VivoSim Labs, Inc. Common Stock

VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 11 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2027	$18.0K	$-1,338,000	$-0.25
FY 2026	$131.0K	$-13,843,000	$-5.35
Q3 2026	$26.0K	$-2,691,000	$-1.03
Q2 2026	$28.0K	$-2,545,000	$-0.98

TickerDaily Coverage

Why Is VivoSim Labs, Inc. Common Stock (VIVS) Stock Up 74.9% Today?

Penny Stocks Marcus Rivera · Jul 15, 2026

VivoSim Labs, Inc. Common Stock (VIVS) exploded 74.9% to $1.48 on massive volume Wednesday, July...

Stock Market Today, July 17, 2026: Penny Stocks Explode as Broad Indexes Hold Steady

Market News David Brooks · Jul 17, 2026

Friday's market session saw a stark divergence between large-cap stability and explosive...

View All Coverage →

Get VIVS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on VivoSim Labs, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.